Literature DB >> 11735846

Sudden cardiac death and antipsychotic drugs: do we know enough?

C A Zarate1, J Patel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11735846     DOI： 10.1001/archpsyc.58.12.1168

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN： 0003-990X


× No keyword cloud information.
  14 in total

1.  Impact of the CSM advice on thioridazine on general practitioner prescribing behaviour in Leeds: time series analysis.

Authors:  Nat M J Wright; Alison J Roberts; Victoria L Allgar; Charlotte N E Tompkins; Darren C Greenwood; Gillian Laurence
Journal:  Br J Gen Pract       Date:  2004-05       Impact factor: 5.386

2.  Cardiac risk and schizophrenia.

Authors:  Ripu Jindal; Erin M MacKenzie; Glen B Baker; Vikram K Yeragani
Journal:  J Psychiatry Neurosci       Date:  2005-11       Impact factor: 6.186

Review 3.  Atypical antipsychotics: from potassium channels to torsade de pointes and sudden death.

Authors:  Karine Titier; Pierre-Olivier Girodet; Hélène Verdoux; Mathieu Molimard; Bernard Bégaud; Wilhelm Haverkamp; Malcolm Lader; Nicholas Moore
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

4.  Omega-3 consumption and sudden unexpected death in schizophrenia: a "fish" a day keeps heart disease away.

Authors:  Fulvio A Scorza; Carla A Scorza; Ana C Fiorini; Jair de Jesus Mari; Leandro Freitas; Josef Finsterer
Journal:  Psychopharmacology (Berl)       Date:  2019-02-26       Impact factor: 4.530

5.  [How much general medical competency does a psychiatrist need?].

Authors:  W Hewer
Journal:  Nervenarzt       Date:  2005-03       Impact factor: 1.214

6.  Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data.

Authors:  Sean Hennessy; Warren B Bilker; Jill S Knauss; David J Margolis; Stephen E Kimmel; Robert F Reynolds; Dale B Glasser; Mary F Morrison; Brian L Strom
Journal:  BMJ       Date:  2002-11-09

Review 7.  A systematic review of the Soteria paradigm for the treatment of people diagnosed with schizophrenia.

Authors:  Tim Calton; Michael Ferriter; Nick Huband; Helen Spandler
Journal:  Schizophr Bull       Date:  2007-06-14       Impact factor: 9.306

Review 8.  Cardiovascular effects of noncardiovascular drugs.

Authors:  Satish R Raj; C Michael Stein; Pablo J Saavedra; Dan M Roden
Journal:  Circulation       Date:  2009-09-22       Impact factor: 29.690

Review 9.  Thalamic nuclear abnormalities as a contributory factor in sudden cardiac deaths among patients with schizophrenia.

Authors:  Fulvio A Scorza; Andrea Schmitt; Roberta M Cysneiros; Ricardo M Arida; Esper A Cavalheiro; Wagner F Gattaz
Journal:  Clinics (Sao Paulo)       Date:  2010-05       Impact factor: 2.365

10.  Analysis of West Virginia medicaid claims data for the prevalence of medical conditions and use of drugs likely to cause QT prolongation in patients with schizophrenia.

Authors:  Iftekhar D Kalsekar; Eugene H Makela; Karen E Moeller
Journal:  Curr Ther Res Clin Exp       Date:  2003-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.